Disc Medicine holder plans Rule 144 stock sale

Disc Medicine, Inc. (IRON) has a shareholder, Atlas Venture Fund X, that filed a notice of proposed resale of common stock under Rule 144.

Rhea-AI Filing Summary

Disc Medicine, Inc. (IRON) has a shareholder, Atlas Venture Fund X, that filed a notice of proposed resale of common stock under Rule 144. The shares were originally acquired from the issuer in a private placement for cash on May 1, 2020, and are expected to be sold through Merrill Lynch on Nasdaq. Additional recent sales over the prior three months are referenced in an attached table.

Key Figures

Acquisition date of shares: May 1, 2020 Date of notice: September 2, 2026

2 metrics

Acquisition date of shares May 1, 2020 Date the common stock was acquired in a private placement for cash

Date of notice September 2, 2026 Date the Rule 144 notice for proposed resale was filed

Key Terms

Rule 144, Private Placement, Nasdaq

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Private Placement financial

"Common Stock | 05/01/2020 | Private Placement | Issuer"

A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

Nasdaq market

"| 38392844 | 09/02/2026 | Nasdaq"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

What does the Rule 144 filing mean for Disc Medicine (IRON)?

The filing shows Atlas Venture Fund X, a shareholder of Disc Medicine, has given notice of intent to resell common stock under Rule 144. This is a resale by an existing holder and does not itself indicate any new issuance of shares by the company.

Who is selling shares of Disc Medicine (IRON) in this Form 144?

The notice is filed for Atlas Venture Fund X, identified as the person for whose account the Disc Medicine common stock is to be sold. The form notes that information must also cover other persons whose sales are aggregated under Rule 144.

How and when were the Disc Medicine (IRON) shares being resold originally acquired?

The common stock covered by the notice was acquired on May 1, 2020 in a private placement from Disc Medicine as the issuer, with the consideration described as cash.

Through which broker and market are the Disc Medicine (IRON) shares expected to be sold?

The proposed sales of Disc Medicine common stock are associated with Merrill Lynch as broker and list Nasdaq as the trading market for the shares.

Does the Form 144 indicate recent sales of Disc Medicine (IRON) shares?

Yes. The notice states, “See attached Table II for sales of securities over the last three months,” indicating there have been sales of the relevant securities in the preceding quarter.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 04:45 PM Accepted by SEC EDGAR 09/02/2026 - 04:44 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001628098
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Disc Medicine, Inc.
SEC File Number	001-39438
Address of Issuer	321 ARSENAL STREET, SUITE 101 WATERTOWN MASSACHUSETTS 02472
Phone	617-674-9274
Name of Person for Whose Account the Securities are To Be Sold	Atlas Venture Fund X, LP
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Shareholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch One Bryant Park New York NY 10036	64460	5071068.2	38392844	09/02/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/01/2020	Private Placement	Issuer			64460	05/01/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	See attached Table II for sales of securities over the last three months.
Date of Notice	09/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Ommer Chohan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)